December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand B8

2017 Edition

DELPHARM BIOTECH

fr

You have identified reliable biomarkers or designed mAb against a bio-target.
You have developed a companion diagnostic tool: immuno assay prototype (ELISA or LFIA) for biomarkers monitoring and you are willing to find a partner to industrialize your device before commercial batch.
Delpharm Biotech, as Immuno Assay contract manufacturing organization (CMO) with all the capabilities, under ISO 13485 can meet your requirement in both veterinary and human diagnostic markets.

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.